Pfizer results | SRPT Message Board Posts

Sarepta Therapeutics Inc.

  SRPT website

  •  Registered Members of Investor Village:
    Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password. 

     MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.  

    For assistance call 888-222-7309 or email

SRPT   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  13807 of 14216  at  6/28/2019 11:45:40 AM  by


 In response to msg 13806 by  euphorbus
view thread

Re: Pfizer results

PFE results were exceptionally poor in several regards. Very little expression data was shown, and what was shown as IF was weak and no western blot data. The trial was halted for toxicity, and two types of toxicity. In contrast SRPT showed strong expression at 96% of normal by western blot and agreed by IF. No SAEs. The fight was stopped by the ref, blood on the mat. PFE is inferior in all regards. Three times the dose half the expression and five times the toxicity

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 244
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by